ST LOUIS CAPE GIRARDEAU CCOP

圣路易斯-吉拉多角CCOP是由六家医院组成的财团，位于 密苏里州东部和西部的两个独立的双州医疗服务区 伊利诺伊州。圣路易斯大都会地区的调查人员是 隶属于财团中五家医院中的一家或多家，以及 在过去的10年里，他们在癌症治疗研究方面共同工作 协议和最近，在癌症控制研究中。好望角 吉拉多的调查人员在过去的四年里一直与CCOP合作 隶属于该市的两家医院。在下一次 五年内，我们希望每年至少获得80个癌症学分 NSABP和SWOG的治疗研究方案和至少100 每年的癌症控制和随访学分(新参与者和后续行动) 预防研究。这些癌症控制学分将派生 主要是因为我们参与了乳腺癌预防试验和 前列腺癌预防试验。 我们将继续为西南肿瘤学提供高质量的数据 小组和国家外科辅助乳房计划是我们的 研究基地，利用期间开发的数据管理系统 过去六年。 总而言之，我们将继续过去10年的出色表现 在癌症治疗研究领域有多年的经验，并利用我们在 癌症控制研究也是如此。过去的经验和 调查人员和数据管理人员的能力提供了坚实的基础 为了这个社区临床肿瘤学项目的持续发展。

The St. Louis - Cape Girardeau CCOP is a consortium of six hospitals in two separate bi-state health service areas in Eastern Missouri and Western Illinois. The investigators from the St. Louis Metropolitan area are affiliated with one or more of the five hospitals in the consortium and have worked together for the past 10 years in cancer treatment research protocols and more recently, in cancer control research studies. The Cape Girardeau investigators have worked with the CCOP for the past four years and are affiliated with the two hospitals in that city. During the next five years, we expect to accrue at least 80 credits per year for cancer treatment research protocols of the NSABP and SWOG and at least 100 credits (new participants and followup) per year for cancer control and prevention studies. These cancer control credits will be derived primarily from our participation in the Breast Cancer Prevention Trial and the Prostate Cancer Prevention Trial. We will continue to provide high quality data to the Southwest Oncology Group and the National Surgical Adjuvant Breast Program which are our research bases, utilizing the data management system developed during the past six years. In summary, we will continue our excellent performance of the past 10 years in the cancer treatment research arena and utilize our expertise in cancer control research studies as well. The past experience and abilities of the investigators and data managers provides a strong base for continuing development of this Community Clinical Oncology Program.